Arteriosklerose und Koronare Herzerkrankung

Zusammenfassung

Heilpilze werden aufgrund ihrer wertvollen therapeutisch wirksamen Inhaltsstoffe als „Medicinal Mushrooms“ zunehmend erforscht und eingesetzt. Insbesondere in der Behandlung der zahlreichen Zivilisationserkrankungen haben sich gute Anwendungsergebnisse gezeigt. Die Mykotherapie bei Arteriosklerose/KHK setzt sehr vielschichtig und bei beinahe allen Ursachen an. Zudem können mit der richtigen Heilpilzauswahl Begleitsymptome therapeutisch berücksichtigt werden.

Der Beitrag gibt einen Überblick zu den wichtigsten Heilpilzen bei Arteriosklerose und KHK.

Abstract

Medicinal mushrooms are increasingly investigated and used due to their valuable therapeutically effective ingredients. Especially in the treatment of numerous civilization diseases good application results have been achieved. Mycotherapy, when used in the treatment of arteriosclerosis/CHD, is very complex and addresses almost all causes. And, with the right choice of medicinal mushrooms, concomitant symptoms can be taken into account therapeutically.

The article gives an overview of the most important medicinal mushrooms for the treatment of arteriosclerosis and CHD.

Schlüsselwörter

Mykotherapie - Heilpilze - Vitalpilze - Arteriosklerose - Koronare Herzkrankheit - KHK

Key words

Mycotherapy - medicinal mushrooms - vitality mushrooms - arteriosclerosis - coronary heart disease - CHD

Publication History

Article published online:
19 February 2020

• Literatur

• 1 Manrique C, Lastra G, Sowers JR. New insights into insulin action and resistance in the vasculature. Ann N Y Acad Sci 2014; 1311 (01) 138-150
• 2 Pathak RK, Middeldorp ME, Meredith M. et al. Long-term effect of goal-directed weight management in an atrial fibrillation cohort: A long-term follow-up study. JACC 2015; 65 (20) 2159-2169
• 3 Mulac K. Pathomechanismen der Atherosklerose bei Diabetes mellitus. Austrian Journal of Cardiology 2005; 12
• 4 Aguilera EM, Suvan J, Buti J. et al. Periodontitis is associated with hypertension: A systematic review and meta-analysis. Cardiovascular Research 2020; 116 (01) 28-39
• 5 McDougall J, Thomas LE, McDougall C. et al. Effects of 7 days on an ad libitum low-fat vegan diet: The McDougall Program cohort. Nutr J 2014; 13: 99
• 6 Yonova D. Role of vitamin K2 on the mineralization and cardiovascular calcification in chronic kidney diseases and renal failure. Dialysis Trans OA 2019; 2 (02) 180010
• 7 Jayachandran M, Xiao J, Xu B. A critical review on health promoting benefits of edible mushrooms through gut microbiota. Int J Mol Sci. 2017 doi: 10.3390/ijms18091934
• 8 Halliwell B, Cheah IK, Tang RMY. Ergothioneine – a diet-derived antioxidant with therapeutic potential. FEBS Lett 2018; 592 (20) 3357-3366
• 9 Elsayed EA, El Enshasy H, Wadaan MAM. et al. Mushrooms: A potential natural source of anti-inflammatory compounds for medical applications. Mediators Inflamm. 2014 doi: 10.1155/2014/805841
• 10 Li Khva Ren, Vasil’ev AV, Orekhov AN. et al. [Anti-atherosclerotic properties of higher mushrooms (a clinico-experimental investigation)]. Voprosy Pitaniia 1989; 1: 16-19
• 11 Sabaratnam V, Mohd Ali S, Kho TT. et al. Fibrinolytic and anticoagulant enzymes of selected medicinal and culinary mushrooms. 7th International Medicinal Mushroom Conference, Beijing, China. 2013
• 12 Chen CJ, Chen YL, Huang SW. Animal trial on hypocholesterämic effect and obese polycystic ovary syndrome (PCOS) women through: A randomized double-blind placebo-controlled clinical trial treated with Auricularia Polytricha Formula. Presentation, International Medicinal Mushrooms Congress 2019, Nantong.
• 13 Sargowo D, Ovianti N, Susilowati E. et al. The role of polysaccharide peptide of Ganoderma lucidum as a potent antioxidant against atherosclerosis in high risk and stable angina patients. Indian Heart Journal 2018; 70 (05) 608-614
• 14 Heriansyah T, Nurwidyaningtyas W, Sargowo D. et al. Polysaccharide peptide (PsP) Ganoderma lucidum: A potential inducer for vascular repair in type 2 diabetes mellitus model. Vasc Health Risk Manag 2019; 15: 419-427
• 15 Jung S, Son H, Hwang CE. et al. Ganoderma lucidum ameliorates non-alcoholic steatosis by upregulating energy metabolizing enzymes in the liver. J Clin Med. 2018 doi: 10.3390/jcm7060152
• 16 Yang H, Hwang I, Kim S. et al. Preventive effects of Lentinus edodes on homocysteinemia in mice. Exp Ther Med 2013; 6 (02) 465-468
• 17 Yang H, Hwang I, Kim S. et al. Lentinus edodes promotes fat removal in hypercholesterolemic mice. Exp Ther Med 2013; 6 (06) 1409-1413
• 18 Afrin S, Rakib A, Kim B. et al. Eritadenine from edible mushrooms inhibits activity of angiotensin converting enzyme in vitro. J Agric Food Chem 2016; 64 (11) 2263-2268
• 19 Cao H, Wang S, Cui X. et al. Taking ingredients as an entry point to explore the relationship between the Shaggy Ink Cap medicinal mushroom, Coprinus comatus (Agaricomycetes), and diabetes mellitus (review). Int J Med Mushrooms 2019; 21 (05) 493-502
• 20 Jayasuriya WJ, Wanigatunge CA, Fernando GH. et al. Hypoglycaemic activity of culinary Pleurotus ostreatus and P. cystidiosus mushrooms in healthy volunteers and type 2 diabetic patients on diet control and the possible mechanisms of action. Phytother Res 2015; 29 (02) 303-309
• 21 Chen X, Zhang XL, Wang CM. et al. Cordyceps sinensis combined with duloxetine improves sleep symptoms in patients with depression: A randomized, double-blind, placebo-controlled study. Asia Pacific Journal of Clinical Trials 2018; 3 (04) 136-145
• 22 Holliday J, Cleaver M. Medicinal value of the Caterpillar fungi species of the Genus Cordyceps (Fr.) Link (Ascomycetes). A Review. Int J Med Mushrooms. 2008 doi: 10.1615/IntJMedMushr.v10.i3.30